The developed genetic panel (PRSS1, SPINK1, CTRC, CFTR, and CPA1 genes) for identification of genetic risk factors of the chronic pancreatitis development and the usage of the next-generation sequencing technology allowed to specify genetic predictors of the disease development in 61% of patients. This evidence concerns the gene CPA1 and chronic pancreatitis.